Construction and evaluation of a novel GalNAc ligand for improvement of pharmacokinetics of hepatocyte-targeting antisense oligonucleotides.

○Chisato Terada Terada

9:48 AM - 10:00 AM

[28V10-am05S] Construction and evaluation of a novel GalNAc ligand for improvement of pharmacokinetics of hepatocyte-targeting antisense oligonucleotides.

○Chisato Terada Terada¹, Fumito Wada², Asako Yamayoshi¹, Mariko Harada-Shiba², Satoshi Obika³, Tsuyoshi Yamamoto¹ (1. Grad. Sch. Biomed. Sci., Nagasaki Univ., 2. NCVC, 3. Grad. Sch. Pharm. Sci., Osaka Univ.)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[28V10-am] ターゲティング①

[28V10-am05S] Construction and evaluation of a novel GalNAc ligand for improvement of pharmacokinetics of hepatocyte-targeting antisense oligonucleotides.

Password